Synonyms: bruneomycin | nigrin | NSC-45383 | rufocromomycin | valacidin
Compound class:
Natural product
Comment: Streptonigrin is an antibacterial with anti-tumour effects ascribed to its substituted quinolinequinoic fragment [3]. Streptonigrin is isolated from Streptomyces flocculus or S. rufochronmogenus. This compound is reported to be a selective inhibitor of protein-arginine deiminase type-IV (PADI4) [1].
The ChEMBL entry for streptonigrin (CHEMBL11417) represents an alternative tautomer to the structure shown here. ![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Although IC50 values appear to show preference for PADI3 inhibition, experiments show that streptonigrin is an irreversible inhibitor which covalently modifies the active site of the enzyme. In addition, as the substrate used in the experiments is a poor substrate for PADI3, this has skewed the results. Additional experiments to calculate the kinact/KI values (a more appropriate measure of irreversible inhibition) point to selectivity for PADI4 [2]. The kinact/KI value for PADI4 is 4.4x105 M-1 min-1 and for PADI3 it is 3.5x103 M-1 min-1 (indicating >120-fold selectivity). |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|